Briscoe-Dwyer Elected Next President of ASHP

Published: August 3, 2023
Leigh A. Briscoe-Dwyer

Gullickson, Moore, and Slain Elected to Board of Directors

Leigh A. Briscoe-Dwyer, PharmD, BSPharm, BCPS, FASHP, has been elected as ASHP's new President-elect. Kristine (Kristi) K. Gullickson, PharmD, MBA, DPLA, FASHP, FMSHP, Dawn M. Moore, PharmD, MS, CPEL, FACHE, and Douglas C. Slain, PharmD, BCPS, FASHP, were elected to serve on the ASHP Board of Directors.

Briscoe-Dwyer is the system director of pharmacy for the UHS Hospitals System in Johnson City, New York. She recently completed a term on the ASHP Board of Directors. Her ASHP service also includes terms as chair of the ASHP Committee on Nominations, Council on Public Policy, and the FASHP Recognition Committee. She served as a New York State delegate to the ASHP House of Delegates for over ten years. She is a past president of the Long Island Society of Health-system Pharmacists and was very active in the New York State Council of Health-system Pharmacists as a board member and presidential officer.

Gullickson is director of pharmacy at Abbott Northwestern Hospital, part of Allina Health in Minneapolis, Minnesota. She is faculty for ASHP’s Manager’s Boot Camp and a multi-year delegate to the ASHP House of Delegates. Her ASHP service also includes terms as chair of the Section of Pharmacy Practice Leaders (SPPL) and Council on Pharmacy Practice, member of SPPL section advisory groups, contributor to the ASHP Leadership Basics Certificate, ASHP expert panel member for the ASHP Guidelines on Preventing Diversion of Controlled Substances, and the ASHP/APhA Medication Management in Care Transitions project. She is a past president of the Minnesota Society of Health-System Pharmacists (MSHP) and represents MSHP on the Minnesota Pharmacy Alliance practice advocacy group.

Moore is the vice president and chief pharmacy officer at Community Health Network in Indianapolis, Indiana, and an affiliate assistant professor at Purdue University and Butler University. She is a member of the ASHP Pharmacy Executive Leadership Alliance and has served as a member of the ASHP Task Force on Racial Diversity, Equity, and Inclusion; ASHP Multi-Hospital Health-System Pharmacy Executive Committee; ASHP Women in Pharmacy Leadership Steering Committee; ASHP Council on Pharmacy Management; and as adjunct faculty to the ASHP Foundation Pharmacy Leadership Academy.

Slain is a professor and infectious diseases clinical specialist at West Virginia University (WVU) School of Pharmacy and WVU Medicine’s J.W. Ruby Memorial Hospital and Clinics. He also serves as the chairman of the clinical pharmacy department. His ASHP service includes chair and director-at-large of the Section of Clinical Specialists and Scientists, chair of the Council on Therapeutics, voting member of the Pharmacy Practice Model Initiative Summit, and member of the 2012-2013 Task Force on Organizational Structure. He has also served as a delegate to the ASHP House of Delegates and as vice president of the West Virginia Society of Health-System Pharmacists.

Briscoe-Dwyer will begin her term immediately. Gullickson, who was elected to fill the remaining two years of the Board term vacated when Sam Calabrese joined ASHP as vice president of the accreditation services office, will also begin her position immediately. Moore and Slain will begin their three-year terms in June 2024.

ASHP thanks the members of the Board of Canvassers for their work to certify the election results. The members of the Board of Canvassers are Mary Binghay (Chair), Chris Ellison, Shabir Somani, and John Spain.





Posted August 3, 2023

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information